Lyan sclerosis is a genital skin condition sharply impacting the quality of life for many individuals. Although it affects approximately 1% of the population, the figures might, in fact, be higher due to underreporting and frequent misdiagnoses.

This condition manifests through serious symptoms such as itching, burning, pain, and tearing of vaginal and vulval tissue. Such effects can severely disrupt everyday activities. People experiencing lyan sclerosis might find ordinary actions like intercourse, going to the toilet, or even wearing certain clothes incredibly challenging.

Within the National Health Service (NHS), the predominant approach involves steroids aimed at halting flare-ups and preventing the condition from worsening. This method, though conventional, serves to manage, not correct, the underlying cause of the flare-ups.

Since 2015, innovative treatment with Platelet-Rich Plasma (PRP) has been utilized to address this condition with "incredible results" in tissue rejuvenation, symptom cessation, and flare-up reduction. This treatment offers a beacon of hope in potentially shifting treatment paradigms from merely controlling symptoms to fostering substantive healing.